心脉医疗: 心脉医疗：关于取消监事会、修订《公司章程》并办理工商变更登记、修订及新增公司部分管理制度的公告

Group 1 - The company has decided to abolish the supervisory board and amend its articles of association, with the audit committee of the board taking over the supervisory functions as per the Company Law [1][2] - The decision to cancel the supervisory board was approved in the eighth meeting of the third board of directors held on August 26, 2025, and will be submitted for approval at the first extraordinary general meeting of shareholders in 2025 [1][2] - The company will revise its articles of association and handle the necessary business registration changes, which will also require approval from the shareholders' meeting [2] Group 2 - The company plans to revise and add certain management systems in accordance with the latest regulations and its actual situation, with some requiring shareholder approval [2] - The revised management systems include regulations on the management of shares held by directors and senior management, which have been approved by the board but require shareholder approval to take effect [2] Group 3 - The company will disclose the revised articles of association and management systems on the Shanghai Stock Exchange website [2][3] - The amendments to the articles of association include changes to the roles and responsibilities of the legal representative and the management of company assets [3][4]